To evaluate the effi ciency of the probiotic strain Lactobacillus plantarum LS/07 in dextran sulphate sodium (DSS) induced acute colitis selected biochemical (activity of β-glucuronidase), microbiological (counts of lactobacilli and coliforms), and immunological (IL-6, IL-8, IL-13, NF-κB, MPO) parameters were assessed. SpragueDawley rats were divided into groups: Control, Acute colitis, and Probiotic. Acute colitis was induced using 5% DSS in drinking water for 7d. DSS induced an infl ammatory process in the colonic tissue, increased the activity of β-glucuronidase (p<0.001), increased the counts of coliform bacteria and decreased lactobacilli counts (p<0.05), and activated the production of the measured parameters (NF-κB, MPO, IL-6, IL-8) except of IL-13. Lactobacillus plantarum LS/07 in the diet alleviated the DSS induced infl ammatory process by inhibiting the production of IL-6, IL-8, the activities of NF-κB and MPO, and stimulated the production of IL-13. The probiotic reduced the activity of β-glucuronidase (p<0.05), increased lactobacilli counts and decreased coliform bacteria. These results indicate that di etary intake of Lactobacillus plantarum LS/07 suppressed the expression of markers playing an important role in the infl ammatory process. We conclude that the anti-infl ammatory properties of Lactobacillus plantarum LS/07 makes its suitable for the prevention or treatment of colitis.
INTRODUCTION
Ulcerative colitis (UC) as a nosological unit within infl ammatory bowel diseases (IBD) represent important chronic multifactorial diseases affecting the gastrointestinal tract in humans, as well as in animal species [1] [2] [3] . The etiology of IBD, as well as ulcerative colitis is unknown. Contributing factors to the pathogenesis of IBD include disturbance of the intestinal microbiota and its metabolites, the host´s genetic susceptibility, and the host´s innate and acquired immunity [4, 5] . Ulcerative colitis is manifested by alternating of acute infl ammation (relapse) and infl ammation in decline (remission). UC is a serious medical and socio-economic problem, an increasing incidence and prevalence, and the decreased quality of life are the reasons for seeking new possibilities for the prevention and treatment. In general, the treatment of UC or IBD usually involves both dietary and pharmacologic intervention, as well as therapeutic manipulation of the enteric microbiota through the use of antibiotics, probiotics, and prebiotics may attenuate the infl ammatory process and benefi cially modulate gut microbiota and intestinal health and possibly protect humans and animals from ulcerative colitis. For the treatment of IBD probiotic products are currently used as supplements, and not as alternatives or substitutes for conventional therapy [6, 7] . Animal studies have confi rmed that probiotics and prebiotics enhance the intestinal mucosal immunity, recover the intestinal microbial community structure, and improve chronic intestinal infl ammation [8] [9] [10] .
The aim of the presented study was to obtain information about the effects of the probiotic strain Lactobacillus plantarum LS/07 on the activity of β-glucuronidase, counts of coliform and lactobacilli in fresh caecal digesta, cytokine levels (IL-6, IL-8, IL-13), nuclear factor kappa beta (NF-kB) and myeloperoxidase (MPO) activities in the colon tissue and blood samples of rats with dextran sulphate sodium (DSS) induced acute colitis.
MATERIAL AND METHODS

Animals and experimental design
Male Sprague-Dawley rats (n = 24, 7 weeks old, 220-290 g body weight) were placed at the Laboratory of Research Bio-models of the Faculty of Medicine, University of P. J. Šafárik, Slovak Republic (SK PC 4013) under standard laboratory conditions. All animal experiments were conducted in accordance with the principles outlined in Law No. 377/2012 and No. 436/2012 of the Slovak Republic for the Care and Use of Laboratory Animals, and were ap proved by the Ethical Committee of the University of P.J. Šafárik, Faculty of Medicine and State Veterinary and Food Administration of the Slovak Republic. The rats were randomly assigned to groups: Control (control group) received the conventional feed (Snina, Slo vak Republic) for 14 days, Acute colitis (acute colitis group) received conventional feed without DSS for 7 days followed by 7 days of feed with DSS, and Probiotic (probiotic group) received conventional feed with probiotic Lactobacillus plantarum LS/07 given in pasteur ized milk containing 0.5% fat at a daily dose 1.5×10 9 CFU/1 mL, without DSS for 7 days and then 7 days simultaneously with DSS ( Figure 1 ). Animals were weighted and clinically monitored daily with free access to water and feed. At the end of the experimental diets, the animals were euthanized under anesthesia (Zoletil, Virbac S.A., France) administered at a dose of 50 mg/kg body weight with Xylazin (Riemser, Germany) at a dose of 15 mg/kg body weight, intramuscular). Samples of blood, caecal digesta and tissue were recovered for biochemical, microbial and immunological analysis.
Acute colitis induction
Acute colitis was induced using DSS (molecular weight 40 000, TdB Consulting AB, Uppsala, Sweden) added to drinking water at a fi nal concentration of 5% (wt/vol) for 7d. Rats in the control group received drinking water only. The DSS solution was replenished daily and DSS consumption was noted per cage at the end of 7d treatment.
Disease activity index
Disease activity index (DAI) is the combined score of animal weight loss, stool consistency and bleeding present in the stool. To these parameters a score was assigned and calculated as average daily disease activity index for each rat as described [11] .
Probiotic strain
The probiotic strain of Lactobacil lus plantarum LS/07 was isolated from rectal human swabs reported by Strojný and coworkers [12] . The strain was cultured in MRS broth (Merck, Germany) pre pared as night cultures at 37ºC aerobically and provided in a dose of 3x10 9 CFU of strain/1 mL. Then 0.5 mL of lactobacilli strains mixed with 9 mL of pasteurized milk (20-22ºC) was fi lled into bottles and administered every day. Each rat received approximately 1.5x10 9 CFU lactobacilli via the oral route.
Bacteriological examination
Microbial analyses (total counts of lactobacilli and coliform) of the fecal samples were carried out after completion of the experiment. For coliforms culturing selective McConkey agar plates (Merck, Germany) incubated aerobically at 37ºC for 16-18 h. were used, and for lactobacilli culturing Rogosa agar plates (Biokar Diagnostics, France) under anaerobic condition incubating at 37ºC for 48 h were used. The numbers of colony forming unis (CFU) are expressed as log 10 CFU per gram of feces. Acute colitis group received CF from day 0 until day 14. At day 8 UC was induced via DSS administration in drinking water. The Probiotic group started administration of probiotic with CF from day 0 until day 14, and at day 8 UC was induced via DSS.
Measurement of caecal β-glucuronidase activity
The activity of β-glucuronidase (β-GLUCUR) was measured in fresh caecal digesta by determining the rate of p-or o-nitrophenol as previously described by Juskiewicz et al. [13] . The reaction contained 0.3 mL substrate solution (5 mM, Sigma Aldrich, USA) p-nitrophenyl-β-D-glucuronide for β-glucuronidase (β-GLUCUR), and 0.2 mL of 1:10 (v/v) dilution of the caecal digesta in 100 mM phosphate buffer (pH 7.0). After incubation p-or o-nitrophenol was quantifi ed after addition of 0.25 M cold sodium carbonate and absorption was measured at 400 nm. A measurement unit of enzymatic activity is expressed as μmol of p-nitrophenol per min per gram digesta.
Assessment of IL-6, IL-8, IL-13, NFkB and MPO
Samples of blood were left to clot for two hours at room tempera ture before centrifugation for 15 minutes at 1 000 × g. The removed serum samples were stored at -20ºC. Colon tissue samples were rinsed in ice cold PBS (pH 7.0-7.2) to thoroughly remove excess blood, cut longitudinally and homogenized in PBS with a homogenizer on ice (Dis perser T10 Basic Ultra Turrax, Germany) and stored overnight at -20ºC. Thereon, two freeze-thaw cycles were performed to break the cell membranes. Next, the ho mogenates were centrifuged for 5 min at 5 000 × g at 4ºC, the supernatant was removed and stored at -20ºC. All endpoints were measured by enzyme-linked immunosorbent assay (ELISA) as follows: nuclear factor kappa beta (NF-kB) in the tissue by USCN Life Science, Inc., USA; interleukin 6 (IL-6) in the blood and tissue by eBioscience, interleukin 8 (IL-8) and interleukin 13 (IL-13) in the tissue by Cusabio Biotech Co., Ltd. China, and MPO in the tissue and blood by BlueGene Biotech Co., China. The fi nal values of each parameter were measured on the Synergy H4 multiplate reader (BioTek Instru ments, Inc. USA).
Statistical analysis
Results are expressed as mean ± standard deviation (SD). Statistical analysis was performed using analysis of variance (ANOVA) with p values (p<0.05) considered to be statistically signifi cant.
RESULTS
The fi nal mean body weight of the animals compared to the initial was in the control group increased by 30.92%, in the acute colitis group by 9.90%, and in the probiotic group by 21.74%.
The aver age value of all daily disease activity index scores showed that the maximum DAI score = 6.5 was in the acute colitis group, a decline in DAI score was observed after application of probiotic Lactobacillus plantarum LS/07 = 3.5. Changes in the monitored parameters correspond to the changes in weight, as well as the results of the DAI score.
Within a short experimental period preventive dietary supplementation with Lactobacillus plantarum LS/07 positively modifi ed activity of β-glucuronidase which is believed to be a biomarker of increased risk of neoplasm was signifi cantly decreased (p˂0.05) in the probiotic group (Table 1) . Acute colitis elevated (non signifi cantly) the number of coliforms and signifi cantly (p˂0.05) decreased the number of lactobacilli in comparison to the control group (Table 1) . Lactobacillus plantarum LS/07 nonsignifi cantly increased lactobacilli counts and decreased counts of coliform bacteria. In Table 2 are shown changes in nuclear factor kappa beta and myeloperoxidase activities in serum (s) and tissue (t) in the control group, acute colitis group and in groups treated with the probiotic. Serum and tissue cytokine levels of IL-6, IL-8 and IL-13 in the control group, acute colitis group, and probiotic groups are shown in Table 3 . 
DISCUSSION
Probiotic bacteria have been defi ned as live microorganisms, which when consumed in adequate amounts, confer a health benefi t for the host. In recent years, the therapeutic and preventive application of probiotics for several gastrointestinal disorders has received increasing attention [14] [15] [16] . The categories of probiotics used today include: bacteria such as lactic acid bacteria (LAB) and Escherichia coli strains (such as E. coli Nissle 1917, which is one of the few examples of non-LAB probiotic), as well as yeast species including most predominantly Saccharomyces boulardii among other.
The goal of this study was to obtain information about the effect of the probiotic strain Lactobacillus plantarum LS/07 administered to DSS-induced acute colitis rats. Experimental and clinical data so far support the hypothesis that probiotic strains can offer the opportunity to prevent or mitigate intestinal infl ammatory lesions and modulate the intestinal microfl ora and the host immune system in gastrointestinal disorders to provide an adjuvant approach to conventional therapy. Ulcerative colitis is the result of interactions between genetical, immunological, microbial and environmental factors, however the exact etiology and pathogenesis is still unclear.
Of the signaling pathways involved in colonic infl ammation, the one triggered by NF-κB plays a key role. The nuclear factor NF-κB pathway has long been considered a prototypical proinfl ammatory signaling pathway, largely based on the role of NF-κB in the expression of proinfl ammatory genes including cytokines, chemokines, and adhesion molecules. NF-κB controls apoptosis, cell-cycle progression, cell proliferation, and differentiation. Normal functioning of NF-κB is essential for the maintenance of epithelial cell homeostasis in the gut. But, the antiapoptotic functions of NF-κB can both protect against infl ammation, in the case of epithelial cell survival and mucosal barrier integrity, and also maintain the infl ammatory response through persistent leukocyte activation [17] .
NF-κB expression in colonic tissues samples was markedly increased in acute colitis groups (p˂0.001) and it may provide a sensitive mean of assessing the state of activation of the mucosal immune response. Application of Lactobacillus plantarum LS/07 decreased colon tissue NF-κB activity slightly. Activated NF-κB in the acute colitis group signifi cantly activated serum and colon tissue levels of pro-infl ammatory cytokines (IL-6 and IL-8) compared with the control group. Lactobacillus plantarum LS/07 signifi cantly down-regulates the synthesis of IL-6 and IL-8 (p˂0.001) in the serum and colon tissue compared to the acute colitis group. Probiotic Lactobacillus plantarum LS/07 stimulated tissue IL-13 production thus demonstrating its antiinfl ammatory activity and immune enhancing effect. Dietary Lactobacillus plantarum LS/07 interferes with signal transduction pathways related to the carcinogenesis process, thereby acting as chemopreventive agents. They include the suppression of NF-κB, induction of apoptosis and anti-infl ammatory effects [18] .
Modulation of the activity of bacterial enzymes was described as one of the mechanisms through which probiotic Lactobacillus plantarum exhibits benefi cial effect. This enzyme, β-glucuronidase, characteristic of harmful bacteria species, has deconjugative properties that support transformation of xenobiotics into more toxic substances. This can lead to high local concentrations of carcinogenic compounds within the gut, thus increasing the risk of carcinogenesis. Furthermore, reuptake of the deconjugated compounds from the gut and reglucuronidation in the liver leads to an enterohepatic circulation of xenobiotic compounds, which increases their retention time in the body. Within a short experimental period preventive dietary supplementation with Lactobacillus plantarum LS/07 positively modifi ed counts of lactobacilli and coliforms and activity of β-glucuronidase (summarized in Table 1 ).
Myeloperoxidase is important to understand its effects on infl ammation, as it is the most abundant proinfl ammatory enzyme stored in the azurophilic granules of neutrophilic granulocytes. Neutrophil accumulation in the infl amed intestinal mucosa is a prominent feature of ulcerative colitis. Extracellular MPO activity gives an estimate of oxidative stress in infl ammatory diseases, while intracellular MPO activity correlates well with tissue neutrophil content [19] . The determination of MPO can be used as one of the non-invasive markers of disease and prediction of relapse, and is also considered as an index of infl ammatory damage. Increased activity of MPO recorded in the serum and colon tissue homogenate of rats was signifi cantly suppressed by the probiotic. The release of MPO correlated to an enhanced local release of the neutrophil activating interleukin-8 [20] .
The presented experimental data demonstrate the ability of food supplements containing probiotic strain Lactobacillus plantarum LS/07 to intervene and affect the pathophysiological process of the development of acute colitis. The exact etiology and pathogenesis of ulcerative colitis is not yet known, and in that regard the use of probiotics can be a suitable form of prevention of acute colitis in humans and in animals.
CONCLUSION
Probiotic Lactobacillus plantarum LS/07 exerted anti-infl ammatory effects and contributed to a rapid recovery of DSS-induced acute colitis. Dietary Lactobacillus plantarum LS/07 interfere with signal transduction pathways related to the carcinogenesis process, thereby acting as chemopreventive agents.
ANTIINFLAMATORNI POTENCIJAL LACTOBACILLUS PLANTARUM LS/07 U SLUČAJEVIMA AKUTNOG KOLITISA PACOVA
HIJOVÁ Emília, BERTKOVÁ Izabela, ŠTOFILOVÁ Jana, STROJNÝ Ladislav, CHMELÁROVÁ Anna, BOMBA Alojz U cilju evaluacije efi kasnosti probiotskog soja Lactobacillus plantarum LS/07 kod pacova kod kojih je akutni kolitis izazvan sa Na-dekstran sulfatom (DSS), procenjivani su biohemijski (aktivnost β-glukuronidaze), mikrobiološki (brojevi laktobacila i koliforma) i imunski (IL-6, IL-8, IL-13, NF-κB, MPO) parametri. Pacovi rase Sprague-Dawley su
